vimarsana.com
  1. Home
  2. Live Updates
  3. Expanded Access Program - Breaking News

Page 24 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Delcath Systems : FDA Approves HEPZATO KIT To Treat Metastatic Uveal Melanoma In Adults

(RTTNews) - The U.S. Food and Drug Administration approved HEPZATO KIT (melphalan/Hepatic Delivery System) as a liver-directed treatment for adult.

Drug administrationMore such health newsAccess programDelcath systems incHepatic delivery systemDelcath systemsExpanded access program

TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCorey davisHarlan weismanInternational dialNational institute of environmental health sciencesPharmaceuticals incCompany quarterly report on formDevelopment agreementUniphar durbin ireland limitedAccess programNational institutes of healthSmall business innovation researchNational institute of allergyVoriconazole inhalation powderTacrolimus inhalation powder

Delcath Systems (DCTH) Announces FDA Approval of HEPZATO KIT

Delcath Systems (DCTH) Announces FDA Approval of HEPZATO KIT
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vojislav vukovicGerard michelNational comprehensive cancer networkAccess programDelcath systems incDrug administrationDelcath systemsHepatic delivery systemComprehensive cancer networkChief executiveExpanded access programDisease control rateRisk evaluationMitigation strategyChief medicalPublic equity

TFF Pharmaceuticals, Inc : TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

TFF Pharmaceuticals, Inc : TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHarlan weismanCorey davisUniphar durbin ireland limitedCompany quarterly report on formNational institute of environmental health sciencesNational institutes of healthInternational dialPharmaceuticals incNational institute of allergySmall business innovation researchAccess programDevelopment agreementVoriconazole inhalation powderTacrolimus inhalation powder

TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHarlan weismanCorey davisAccess programNational institute of environmental health sciencesDevelopment agreementInternational dialNational institute of allergySmall business innovation researchNational institutes of healthUniphar durbin ireland limitedCompany quarterly report on formPharmaceuticals incVoriconazole inhalation powderTacrolimus inhalation powder
© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.